Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India's Orchid Establishes Japanese Subsidiary

This article was originally published in PharmAsia News

Executive Summary

Indian pharmaceutical company Orchid Chemicals and Pharmaceuticals set up a Japanese subsidiary, Orchid Pharma Japan, the company announced April 10. Orchid Managing Director C.B. Rao commented the Tokyo-based branch will tap the rapidly growing Japanese generics market, and plans to launch five to ten drugs and reach ¥10 billion in sales in five years. Orchid Pharma Japan President Kunihiko Iwate said the short term goal for the company is to strengthen sales in the Japanese generics market. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts